AyoxxA Biosystems GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AyoxxA Biosystems GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11207
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing services, biochip readout services, biomarker screening, selection and validation, custom panel configuration, and custom multiplex assay development. AyoxxA’s products are used in the analysis of serum, cell culture supernatant, ocular disorders, aqueous humor and vitreous humor matrices. The company markets its products through a network of distributors in Germany, Singapore and the US markets. AyoxxA is headquartered in Koln, Germany.

AyoxxA Biosystems GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AyoxxA Biosystems GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 11
Ayoxxa Biosystems Raises USD12 Million in Series B Financing 12
AyoxxA Biosystems Raises US$0.5 Million In Second Tranche Of Series A Financing 14
AyoxxA Biosystems Raises USD3.4 Million in Series A Financing 16
Partnerships 17
Ayoxxa Biosystems Completes Research Collaboration With Grunenthal 17
Ayoxxa Biosystems Enters Into Research Agreement With NUS For Protein Analysis Technology Development 18
AyoxxA Biosystems GmbH – Key Competitors 19
AyoxxA Biosystems GmbH – Key Employees 20
AyoxxA Biosystems GmbH – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
Dec 05, 2017: AYOXXA Launches LUNARIS Human 11-Plex Ophthalmology Kit 22
Apr 18, 2018: AYOXXA launches LUNARIS Human 12-Plex Th17 Kit expanding its portfolio for fully scalable biomarker analysis 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Key Facts 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AyoxxA Biosystems GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
AyoxxA Biosystems GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 11
Ayoxxa Biosystems Raises USD12 Million in Series B Financing 12
AyoxxA Biosystems Raises US$0.5 Million In Second Tranche Of Series A Financing 14
AyoxxA Biosystems Raises USD3.4 Million in Series A Financing 16
Ayoxxa Biosystems Completes Research Collaboration With Grunenthal 17
Ayoxxa Biosystems Enters Into Research Agreement With NUS For Protein Analysis Technology Development 18
AyoxxA Biosystems GmbH, Key Competitors 19
AyoxxA Biosystems GmbH, Key Employees 20
AyoxxA Biosystems GmbH, Subsidiaries 21

List of Figures
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AyoxxA Biosystems GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AyoxxA Biosystems GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korea East-West Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Medifast Inc (MED):企業の財務・戦略的SWOT分析
    Medifast Inc (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …
  • Meril Life Sciences Pvt Ltd:企業の製品パイプライン分析2018
    Summary Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. …
  • Gunvor Group Ltd:企業の戦略的SWOT分析
    Gunvor Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • China International Marine Containers (Group) Co Ltd:企業のM&A・事業提携・投資動向
    China International Marine Containers (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China International Marine Containers (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes busines …
  • Cenovus Energy Inc (CVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves in Athabasca region of northeaste …
  • InSphero AG:製薬・医療:M&Aディール及び事業提携情報
    Summary InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture p …
  • maxingvest ag:企業の戦略・SWOT・財務分析
    maxingvest ag - Strategy, SWOT and Corporate Finance Report Summary maxingvest ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Allergan Plc (AGN):医療機器:M&Aディール及び事業提携情報
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Kimball International, Inc.
    Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ansvar Insurance Limited:企業の戦略・SWOT・財務分析
    Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Integrated DNA Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • Epcor Utilities Inc:企業の発電所・SWOT分析2018
    Epcor Utilities Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Duke Energy Corporation:企業の戦略・SWOT・財務情報
    Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vision RT Ltd:企業の戦略的SWOT分析
    Vision RT Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆